GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers.
“GLP-1 receptor agonists have never been just glucose-lowering drugs,” said Dr. Marcin Chwistek, chief of the supportive…
Doctors Say These Are The Side Effects Of GLP-1s That Everyone Should Really, Really, Really Know About
Thursday, May 28 – Thursday, May 28 – “These medications also come with risks that aren’t as freely talked about as their benefits.”View Entire Post ›
Lilly’s New Drug Yields Dramatic Weight Loss, Rivaling Bariatric Surgery, GLP-1s
Wednesday, May 27 – A new experimental weight loss drug from Eli Lilly shows dramatic results that rival current GLP-1 drugs and bariatric surgery. Image Credit: Scott Olson/Getty Images
Eli Lilly recently announced phase 3 trial results for a promising new weight loss drug retatrutide.
The dramatic results from the TRIUMPH-1 trial represent the greatest weight loss observed in a medication trial, rivaling current GLP-1 drugs and bariatric surgery.
Trump’s Medical Exam; Ebola Outpacing Response; Eating Disorders and GLP-1s
Wednesday, May 27 – (MedPage Today) — Note that some links may require registration or subscription.
President Donald Trump is expected to have a medical exam today at Walter Reed National Military Medical Center, marking the third such appointment in 13 months…
Keeping weight off might not require full-dose GLP-1 drugs, trials suggest
Tuesday, May 26 – Keeping weight off might not require full-dose GLP-1 drugs, trials suggest
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
Tuesday, May 26 – New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
AI scans 400,000 Reddit posts and finds hidden Ozempic side effects
Monday, May 25, – By analyzing over 400,000 Reddit posts, researchers discovered that users of popular GLP-1 weight-loss drugs frequently discussed unexpected symptoms like menstrual irregularities, chills, and hot flashes. The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss.
Doctors Reveal The Most Common Side Effects Of GLP-1s — And How To Manage Them
Monday, May 25, – Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.
Popular weight loss drugs like Wegovy may also target arthritis inflammation
Sunday, May 24 – Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment.
Eli Lilly says its next gen obesity drug is more powerful than Zepbound and Wegovy
Sunday, May 24 – Eli Lilly announced clinical trial results for retatrutide, its next gen obesity drug. The drug helped study participants lose 70 lbs over 80 weeks, making it more powerful than Zepbound and Wegovy.